Marc Beer

Marc Beer has recently moved up the ranks in his position at LumeNXT Inc. He was recently named Chairman of the Board. This is a huge step in his career. LumeNXT is a company that is privately owned and focuses their work mainly on the development of surgical products that help with minimally invasive surgeries. Marc Beer has a lot of experience working with things like this so he is very good at his job. 

Follow Marc Beer Facebook


Marc Beer loves working with a company that is so dedicated to what they do. He knows that the job of LumeNXT will continue to increase in value as more and more surgeries become available for being minimally invasive. Marc Beer along with some of the highest up surgeons know that technology is what helps drive minimally invasive surgeries. Without technology, surgeons would have trouble with visualization, precision, and many other things. 


LumeNXT tries to offer the products that they create at low-cost options. A lot of their products are offered in a disposable way. Their products have helped to raise the success rate of minimally invasive products for many years. Marc Beer is proud to be a part of such an amazing company that is doing great things. After many years of success with LumeNXT Marc Beer decided to start his own business called Renovia Inc. This company is helping to create products for women suffering from pelvic floor disorders. He started this company around the year 2016.


Marc Beer is changing the world one patient at a time. Through his work with both companies, he is helping to create products that are going to be around for a very long time. Marc Beer is already very successful thanks to LumeNXT but having his own company now is really going to take his success on to the next level. There is no stopping him now. Marc Beer is going to see nothing but success for many more years and he is going to take these two companies up the ladder with him. There is no telling just how far he will go. Learn more:

Marc Beer Finds the Perfect Job at LumeN XT

Marc Beer is an experienced salesman specializing in the medical field. He has played a crucial part in the commercialization of dozens of drugs. He brings to the table over 25 years of experience. His career has been a trail of repeated success stories. He founded Renovia and successfully managed to raise funds with the help of his close friend and colleague Yolanda Lorie. In 2000, Marc Beer was appointed as the acting CEO of ViaCell. ViaCell is a biotechnology company that specializes in the storage and manipulation of umbilical cord blood stem cells for future use. Over a cause of seven years, he has led the company from one triumph to another. The company was able to enlist some of the wealthiest women in its clientele. The company was acquired seven years later after going public with an initial public offer.


While working at ViaCell, Marc Beer was also an active member of the board of directors at Erytech Pharma. Erytech Pharma was at the time a biopharmaceutical company. Prior to founding ViaCell, Marc Beer performed various roles at Genzyme. He was tasked with responsibilities such as the commercial launch of several products that addressed people affected by rare diseases all over the world. During his years working in these different companies, he gained invaluable experience that earned him a spot at LumeN XT as chairperson of the board. Learn more:


Marc Beer’s new role at LumeN XT


Any medical professional would be fascinated by the innovations that are being advanced by lumeN XT. With Marc Beer as the new chairperson of the board, the company is sure to make better advancements in the surgical field. The company has been working to develop tools that can be used to enable surgeons to see the human body without having to use invasive techniques. Should the technology be advanced, many surgeries can be performed without invasive procedures, making them simpler and improving the healing processes.


In an interview, Marc Beer stated that he was humbled to be picked for the position as well as excited to venture into this new creative and innovative field. He expressed his gratitude for the team of dedicated and hard working professionals that he will be working with. The new approach to surgery could make the treatment of certain diseases less life-threatening in-turn, reducing the mortality rate. The company planned to use heat reduction technologies to increase the accuracy of vision by up to 20%. Precise vision also enhances the efficiency of the surgeon as well as the effectiveness of the surgery as an option for treatment. Marc Beer expressed his motivation to push forward with the research and ensure that the best goals are achieved within the shortest time possible. With his excellent record, Marc Beer is sure to accomplish great things at LumeN XT.


Paul Mampilly Suggests Grabbing Lyft’s Stocks Right Now

Uber may be the ride share service most Americans know, but it’s possible their “little brother” competitor Lyft could overtake them if the aftermath of their upcoming IPO goes as planned. Successful investment expert Paul Mampilly is telling his regular readers that Lyft is primed to go from its current valuation at $850 million to being worth over $21 billion after it goes public. But it’s not just Lyft stocks alone that are poised to benefit from the IPO Mampilly says. Companies like GM and China’s Alibaba also should see their stocks get a boost, but there’s also another lesser known company that Paul Mampilly says will boom as Lyft’s stock goes up. The information on this company is available to “Extreme Fortunes” subscribers.

Paul Mampilly took up newsletter writing a few years ago more as a hobby than a business. He previously spent much of his professional career in banking and investment advisory services after completing his bachelor’s and master’s degrees in finance and accounting. He first joined Deutsche Bank in 1991 and also worked with ING and Banker’s Trust over the first 10 or so years of his career. Mampilly ran a consulting firm for a few years, but then took a major step up when he joined Kinetics International Fund, a hedge fund that became the talk of Barron’s magazine after he joined and reported gains of 26℅ annually in the firm’s specialized funds.

Mampilly also won an award for taking $50 million that a client gave him and investing it in stocks that were unaffected by the 2008 recession and made a 76℅ gain in one year. Paul Mampilly has found many diamonds in the rough when it’s come to early stage companies, some of which have included Facebook, OLED Universal, Netflix and Sarepta Therapeutics. He quit the mainstream financial industry and Wall Street scene because he felt he needed more time to spend with his family, and writing his own newsletters gave him a chance to reach regular middle class people that most hedge fund and private equity firms don’t reach out to. Mampilly’s newsletters have come with video tutorials and even at times a look at his own portfolio to make them easier to understand. To subscribe to Paul Mampilly’s newsletters, you can find him at

JHSF/José Auriemo Neto: Getting High-Quality Real Estate Guidance

Are you searching for a renowned real estate company to help you succeed in real estate investing? Do you want to get advice and guidance from a professional who is well known for rendering his outstanding service to clients? JHSF is a well-established property developer. JHSF has excellent resources and systems in place, which enable its talented professionals to handle their projects effectively. Perhaps you have read or heard about the success of JHSF and its team. This company has been in business since 1972 and is known around the world. José Auriemo Neto is chairman and CEO of JHSF and he has a great reputation among his clients and peers. He is one of Brazil’s top-rated real estate professionals and he has great expertise in property development.

Many real estate professionals are keen to take their business to the next level and enter into property development. It is important to keep in mind that it takes great effort and a lot of time to achieve success as a property developer. That’s why it is recommended that you get proper training. Before we dive into the real estate investment or property development field, it is a good idea to consult a professional who is well versed in the industry and can help you make the right decisions for your situation. There are several steps involved in running a real estate business and a reliable professional like José Auriemo Neto can advise and guide you.

The key to making great amounts of money in property development is to learn what works and carefully implement the steps. It is also advisable to build a team and get access to the financial resources you need to complete the project successfully. If you’re intent on acquiring and developing real estate property, it’s imperative that you have a good understanding of the process by getting coaching or training in real estate. José Auriemo Neto knows what works and what doesn’t in this business and he has the resources and industry connections to help his clients reach their goals. Read more.


HGGC Is Reliable Private Equity Firm

Private equity firms raise a large amount of money from affluent investors. The funds are then re-invested in a wide range of lucrative opportunities or investment vehicles in order to obtain the biggest possible profit.

HGGC is a top-rated private equity firm and has clients around the globe. The company has a team of highly knowledgeable and experienced professionals and comes highly recommended in the industry.

Private equity firms often grab headlines for leveraged buyouts and large acquisitions. Although there are many firms in this industry, a handful of firms, including HGGC are recognized as the most successful and leading private equity firms.

The private equity sector attracts a lot of attention due to the many benefits it offers to investors and organizations. Numerous individuals and institutional investors have reached their financial through the services and guidance provided by reputable private equity firms.

HGGC has been around for many years and is focused on leveraged buyouts, recapitalizations, corporate carve-outs, platform investments, add-on acquisitions, growth equity, public to private, corporate carve-outs, mid-cap private and public companies and restructuring in the middle market.

Private equity investment comes from high-net-worth individuals and investors who can come up with substantial sums of money. In most cases, these investors are required to dedicate the money for considerably long holding periods.

As a well-established firm, HGGC seeks to invest in industrial services, manufacturing, consumer products, business services, financial services, software, chemicals, infrastructure, healthcare, technology sectors, and information services. The firm primarily invests in North America and also seeks to invest in other countries.

Private equity firms work hard to protect the interests of their clients and feel more secure if they get more control on the board. They want to be able to influence the management of the organization.

Successful investing stems from a superior deal flow and vast experience, disciplined investment choices and aligned interests.

The team at HGGC makes it a priority to negotiate all aspects of the transaction in order to ensure that the shareholders’ agreement is balanced. Their aim is to have a system where both parties are protected.

The Bucks Rise To The Top With Wes Edens

Wes Edens is the co-founder and CEO, Fortress Investment LLC. Buying Milwaukee Bucks meant a long-term commitment for Wes Edens and his Co founder, Marc Lasry. The unit required some literal building, both for upgrading and maintenance as well. The pair had a couple of goals to achieve. The billionaire bucks managers, however, understood that success does not come overnight. They were ready to work for it. About Wes Edens and Lasry believed that they’d bring about the desired change in about 5 years. Growth requires resilience and patience. The Bucks wasn’t an exception. The New York-based duo was proud of their achievements when they joined the NBA at the all-star weekend.

They had collectively grown the franchise from $ 550 million to a whopping $ 1.35 billion. Challenges and disappoints are part of every journey. Lasry admits that there were a handful of challenges in the journey towards the peak. The work involved several firings and hiring. His financial journey was very fulfilling. Raising the money for the construction projects wasn’t such a huddle. Wes Edens notes that the business turned out just as good. He refrains from clarifying how good it was because popular opinion could be different. Wes Edens says that they could be so good theoretically, ruling out possibilities of tussles. They handled the challenges proactively combating the chances of flopping.

Although the team’s projects were flourishing, the Bucks were at risk of falling to mediocre management. After a series of firings, Wes Edens and Marc Lasry settled on Jon Horst for the position of general manager. At this point, everything seemed to be going in Horst’s favor. Edens and Lasry nominated him to the executive of the year award in consensus. Admitting Jon Horst’s importance to Milwaukee Bucks, Wes Edens noted that the lad’s productivity was remarkable. Noting that the Bucks are one data driven entity, Edens said that the team’s selections required substantial analytics and data backing. The judgments must be subject to performance. The Bucks constant rise has made them a worthy contender in NBA festivities. Their game has been outstanding lately. Click here.


Renovia Was Founded On Innovation And The Desire To Treat Illnesses By Marc Beer

Renovia is an up and coming biotech company that was founded in Boston that specializes in Pharmaceuticals, diagnostics, devices, and biotechnology. Renovia was co-founded by Marc Beer, a man with more than 20 years of experience in the pharmaceutical industry and as an entrepreneur. Marc is constantly on the outlook for new growth at Renovia and he has his heart set on new innovations to facilitate new growth. Tens of millions of dollars have gone into research at Renovia already in the past couple of years and Marc was able to acquire another 42 million to extend operations and do new research from their second funding round. Learn more:


Thanks to the innovative new treatments and technology that Renovia is coming up with, many more possibilities are being found when it comes to women’s health. It is estimated that there are more than 250 million people around the world facing urinary incontinence and other symptoms related to pelvic floor disorder. This new treatment that has been discovered by Renovia comes in the form of a digital health platform known as Leva. Leva uses sensory technology in order to gather specific information relating to patients and then provides them with ways to treat their own pelvic floor disorder. Although Renovia has only been in the biotech market for three years, the FDA already approved their Leva product, though it is still going through testing and upgrades.


Marc Beer has been committed to the pharmaceutical industry for decades and he is also a well-established entrepreneur. His enthusiastic personality and determination to succeed are what has driven him to make discoveries others have yet to find. Over the course of his career, Marc Beer has made many contributions to the biotech industry with intelligent innovations that have gone on to help thousands of people. In the past, Marc has worked with many other biotech companies focused on pharmaceuticals, including Biotechnology Innovation Organization, Abbot Laboratories, and Genzyme. Renovia is already on the road to success with generous funding and continued growth on all levels in just a few years. Marc has had experience as a leader at his company Good Start Genetics, which has contributed to his success with Renovia. Follow Marc Beer on LinkedIn